OA09475A - "Dérivés du (N-méthyl-N-alcoyl)amino-3 méthoxyméthylène-2 propane 1-o1, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant". - Google Patents
"Dérivés du (N-méthyl-N-alcoyl)amino-3 méthoxyméthylène-2 propane 1-o1, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant".Info
- Publication number
- OA09475A OA09475A OA59924A OA59924A OA09475A OA 09475 A OA09475 A OA 09475A OA 59924 A OA59924 A OA 59924A OA 59924 A OA59924 A OA 59924A OA 09475 A OA09475 A OA 09475A
- Authority
- OA
- OAPI
- Prior art keywords
- methoxymethylene
- propane
- derivatives
- amino
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000001294 propane Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898928580A GB8928580D0 (en) | 1989-12-19 | 1989-12-19 | 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09475A true OA09475A (fr) | 1992-11-15 |
Family
ID=10668132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59924A OA09475A (fr) | 1989-12-19 | 1990-12-19 | "Dérivés du (N-méthyl-N-alcoyl)amino-3 méthoxyméthylène-2 propane 1-o1, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant". |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5118674A (fr) |
| JP (1) | JPH04208256A (fr) |
| KR (1) | KR910011759A (fr) |
| AR (1) | AR246742A1 (fr) |
| AT (1) | AT400333B (fr) |
| AU (1) | AU630056B2 (fr) |
| BE (1) | BE1004089A3 (fr) |
| CA (1) | CA2032224C (fr) |
| CH (1) | CH681624A5 (fr) |
| DE (1) | DE4040685A1 (fr) |
| DK (1) | DK171298B1 (fr) |
| DZ (1) | DZ1471A1 (fr) |
| ES (1) | ES2023607A6 (fr) |
| FI (1) | FI906162A (fr) |
| FR (2) | FR2656797B1 (fr) |
| GB (2) | GB8928580D0 (fr) |
| GR (1) | GR1000893B (fr) |
| HK (1) | HK118093A (fr) |
| IE (1) | IE65888B1 (fr) |
| IN (1) | IN173969B (fr) |
| IT (1) | IT1243412B (fr) |
| LU (1) | LU87853A1 (fr) |
| MA (1) | MA22013A1 (fr) |
| MY (1) | MY104781A (fr) |
| NL (1) | NL9002582A (fr) |
| NO (1) | NO177146C (fr) |
| NZ (1) | NZ236213A (fr) |
| OA (1) | OA09475A (fr) |
| PT (1) | PT96265B (fr) |
| SE (1) | SE469383B (fr) |
| TN (1) | TNSN90152A1 (fr) |
| ZA (1) | ZA909663B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6551623B1 (en) | 1993-09-09 | 2003-04-22 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
| NZ273258A (en) | 1993-09-09 | 2000-01-28 | Lorus Therapeutics Inc | Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF |
| JPH11501634A (ja) | 1995-03-16 | 1999-02-09 | イムテック ファーマ インコーポレイテッド | 免疫系異常治療用の胆汁からの免疫調節組成物 |
| US20040101569A1 (en) * | 1996-05-16 | 2004-05-27 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
| DE19711758C2 (de) * | 1997-03-21 | 2003-06-18 | Degussa | Verfahren zur Herstellung von 1,3-Dioxanverbindungen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732263A1 (de) * | 1977-07-16 | 1979-02-01 | Schuler Gmbh L | Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders |
| DE2820893C2 (de) * | 1978-05-12 | 1986-02-20 | A. Nattermann & Cie GmbH, 5000 Köln | Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen |
| US4737518A (en) * | 1984-04-03 | 1988-04-12 | Takeda Chemical Industries, Ltd. | Lipid derivatives, their production and use |
| WO1989007099A1 (fr) * | 1988-02-05 | 1989-08-10 | Schering Corporation | Glycerol 2,2-disubstitue et composes analogues au glycerol, compositions et modes d'utilisation |
| JP2534893B2 (ja) * | 1988-06-24 | 1996-09-18 | 日本ケミファ株式会社 | 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤 |
| DE3906952A1 (de) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel |
| GR1000688B (el) * | 1989-12-22 | 1992-10-08 | Sod Conseils Rech Applic | Μεθοδος παρασκευης παραγωγων γλυκερινης. |
-
1989
- 1989-12-19 GB GB898928580A patent/GB8928580D0/en active Pending
-
1990
- 1990-11-16 IN IN1132DE1990 patent/IN173969B/en unknown
- 1990-11-16 GR GR900100812A patent/GR1000893B/el unknown
- 1990-11-26 NZ NZ236213A patent/NZ236213A/xx unknown
- 1990-11-26 CH CH3736/90A patent/CH681624A5/fr not_active IP Right Cessation
- 1990-11-27 NL NL9002582A patent/NL9002582A/nl not_active Application Discontinuation
- 1990-11-27 US US07/618,700 patent/US5118674A/en not_active Expired - Fee Related
- 1990-11-28 ES ES9003036A patent/ES2023607A6/es not_active Expired - Fee Related
- 1990-11-30 ZA ZA909663A patent/ZA909663B/xx unknown
- 1990-11-30 MY MYPI90002111A patent/MY104781A/en unknown
- 1990-12-05 AR AR90318536A patent/AR246742A1/es active
- 1990-12-06 LU LU87853A patent/LU87853A1/fr unknown
- 1990-12-10 MA MA22288A patent/MA22013A1/fr unknown
- 1990-12-12 NO NO905373A patent/NO177146C/no unknown
- 1990-12-13 CA CA002032224A patent/CA2032224C/fr not_active Expired - Fee Related
- 1990-12-14 BE BE9001201A patent/BE1004089A3/fr not_active IP Right Cessation
- 1990-12-14 FI FI906162A patent/FI906162A/fi not_active IP Right Cessation
- 1990-12-16 DZ DZ900227A patent/DZ1471A1/fr active
- 1990-12-18 GB GB9027421A patent/GB2239239B/en not_active Expired - Fee Related
- 1990-12-18 AU AU68142/90A patent/AU630056B2/en not_active Ceased
- 1990-12-18 IE IE456790A patent/IE65888B1/en not_active IP Right Cessation
- 1990-12-18 SE SE9004039A patent/SE469383B/sv unknown
- 1990-12-18 DK DK299590A patent/DK171298B1/da not_active IP Right Cessation
- 1990-12-18 KR KR1019900020921A patent/KR910011759A/ko not_active Application Discontinuation
- 1990-12-19 FR FR909015900A patent/FR2656797B1/fr not_active Expired - Fee Related
- 1990-12-19 DE DE4040685A patent/DE4040685A1/de not_active Ceased
- 1990-12-19 TN TNTNSN90152A patent/TNSN90152A1/fr unknown
- 1990-12-19 IT IT02243890A patent/IT1243412B/it active IP Right Grant
- 1990-12-19 FR FR909015901A patent/FR2656307B1/fr not_active Expired - Fee Related
- 1990-12-19 PT PT96265A patent/PT96265B/pt not_active IP Right Cessation
- 1990-12-19 AT AT0259590A patent/AT400333B/de not_active IP Right Cessation
- 1990-12-19 JP JP2417907A patent/JPH04208256A/ja active Pending
- 1990-12-19 OA OA59924A patent/OA09475A/fr unknown
-
1993
- 1993-11-04 HK HK1180/93A patent/HK118093A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2382441A1 (fr) | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides utiles en tant que medicaments et procedes pour leur preparation | |
| PT75848A (en) | 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles a processfor the preparation thereof a pharmaceutical composition comprising the same and their use as medicaments | |
| FR2403989A1 (fr) | Nouveaux derives a-halogenomethyles d'amines utiles comme medicaments et procedes de leur preparation | |
| ES2017498B3 (es) | Derivado de 2-fenilbenzoxepina. | |
| FR2374307A1 (fr) | Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant | |
| OA09209A (fr) | "Dérivés de la thiéno-triazolo-diazépine, un procédé de préparation desdits composés et une composition thérapeutique les contenant". | |
| OA09336A (fr) | Dérivés du glycérol, un procédé de préparation de ces dérivés et des compositions thérapeutiques les contenant. | |
| OA09442A (fr) | Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant. | |
| DZ1652A1 (fr) | Dérivés de 4,13-dioxabicylo Ä8,2,1Ütridecenone, procédé et produits intermédiaires pour leur préparation et médicaments contenant ces composés. | |
| FR2707085B1 (fr) | Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| OA09475A (fr) | "Dérivés du (N-méthyl-N-alcoyl)amino-3 méthoxyméthylène-2 propane 1-o1, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant". | |
| OA09446A (fr) | "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant". | |
| OA09201A (fr) | "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant". | |
| FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
| OA07984A (fr) | Procédé stéréocontrolé de préparation d'acetoxyazetidione. | |
| OA09349A (fr) | "Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
| FR2691461B1 (fr) | Dérivés de cycloheptimidazole, procédé pour les préparer et composition pharmaceutique et agents thérapeutiques les contenant. | |
| OA09330A (fr) | "Nouveaux dérivés du sélénophène, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant". | |
| FR2713644B1 (fr) | Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| DZ2721A1 (fr) | Dérivés de 11-acétyl-12,13-dioxabicycloÄ8.2.11 tridecenone procédé pour leur préparation et médicaments contenant ces composés. | |
| OA07840A (fr) | Dérivés de la chloro-4-furo-(3,4-c)-pyridine, leur procédé de préparation et compositions thérapeutiques à base de ces dérivés. | |
| FR2693722B1 (fr) | Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant. | |
| FR2691464B1 (fr) | Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments. | |
| OA09139A (fr) | Nouveaux dérivés de la carbonyl-2 N, N'-di-(triméthoxy-benzoyle) pipérazine, un procédé pour leur préparation et compositions thérapeutiques en contenant. | |
| HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof |